Brainstorm Cell Therapeutics Inc. (BCLI)
NASDAQ: BCLI · IEX Real-Time Price · USD
0.382
-0.016 (-4.02%)
May 3, 2024, 3:44 PM EDT - Market open
BCLI Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for BCLI.
Analyst Consensus: Hold
Analyst Ratings
According to 1 stock analyst, the rating for BCLI is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 28, 2023 |
Maxim Group | Maxim Group | Strong Buy Maintains $5 → $10 | Strong Buy | Maintains | $5 → $10 | +2,515.75% | Mar 31, 2023 |
Maxim Group | Maxim Group | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Feb 5, 2021 |
Maxim Group | Maxim Group | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Aug 17, 2017 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.48
from -0.40
EPS Next Year
-0.48
from -0.48
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | n/a | 468.1M | 748.9M |
Avg | n/a | n/a | n/a | 454.7M | 727.5M |
Low | n/a | n/a | n/a | 436.9M | 698.9M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | 64.7% |
Avg | - | - | - | - | 60.0% |
Low | - | - | - | - | 53.7% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -0.49 | -0.49 | -0.62 | 3.15 | 5.29 |
Avg | -0.48 | -0.48 | -0.60 | 3.06 | 5.14 |
Low | -0.46 | -0.46 | -0.58 | 2.94 | 4.94 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | 72.9% |
Avg | - | - | - | - | 68.0% |
Low | - | - | - | - | 61.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.